These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


631 related items for PubMed ID: 26724667

  • 1. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia.
    Zhou WL, Wu HB, Wang LJ, Tian Y, Dong Y, Wang QS.
    Eur J Radiol; 2016 Jan; 85(1):205-210. PubMed ID: 26724667
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
    Sawicki LM, Grueneisen J, Schaarschmidt BM, Buchbender C, Nagarajah J, Umutlu L, Antoch G, Kinner S.
    Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
    [Abstract] [Full Text] [Related]

  • 3. 18F-FDG PET/CT Radiomic Analysis with Machine Learning for Identifying Bone Marrow Involvement in the Patients with Suspected Relapsed Acute Leukemia.
    Li H, Xu C, Xin B, Zheng C, Zhao Y, Hao K, Wang Q, Wahl RL, Wang X, Zhou Y.
    Theranostics; 2019 Feb; 9(16):4730-4739. PubMed ID: 31367253
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.
    Kawata S, Imaizumi M, Kako Y, Oku N.
    Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A.
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 18F-FDG PET/CT in patients with adult-onset Still's disease.
    Dong MJ, Wang CQ, Zhao K, Wang GL, Sun ML, Liu ZF, Xu L.
    Clin Rheumatol; 2015 Dec; 34(12):2047-56. PubMed ID: 25711875
    [Abstract] [Full Text] [Related]

  • 15. Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma.
    Karunanithi S, Sharma P, Roy SG, Vettiyil B, Sharma A, Thulkar S, Bal C, Kumar R.
    Clin Nucl Med; 2014 Sep; 39(9):772-6. PubMed ID: 25036015
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
    Zhou WL, Wu HB, Weng CS, Han YJ, Wang M, Huang S, Wang QS.
    Nucl Med Commun; 2014 Nov; 35(11):1107-11. PubMed ID: 25144562
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
    Kaneuchi Y, Hakozaki M, Yamada H, Hasegawa O, Tajino T, Konno S.
    Hell J Nucl Med; 2016 Nov; 19(1):46-8. PubMed ID: 26929940
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.